ABAX Abaxis, Inc. (delisted)

Reminder - ABAXIS to Report Fiscal 2005 Year End Financial Results Thursday, April 28, 2005 UNION CITY, Calif., April 28 /PRNewswire-FirstCall/ -- ABAXIS, Inc. (NASDAQ:ABAX), a medical products company manufacturing point-of-care blood analysis systems, has scheduled a conference call to discuss its financial results for the fourth quarter and year ended March 31, 2005. The call will be at 4:15 p.m. ET Thursday, April 28, 2005. Participants can dial (877) 356-5706 or (706) 643-0580 to access the conference call, or can listen via a live Internet web cast, which can be found at http://www.abaxis.com/. A replay of the call is available by visiting http://www.abaxis.com/ for the next 30 days or by calling (800) 642-1687 or (706) 645-9291, access code 5524467, through May 28, 2005. About Abaxis ABAXIS develops, manufactures and markets portable blood analysis systems for use in any patient-care setting to provide clinicians with rapid blood constituent measurements. The system consists of a compact, 6.9 kilogram, portable analyzer and a series of 8-cm diameter single-use plastic disks, called rotors or reagent discs that contain all the reagents necessary to perform a fixed menu of tests. The system can be operated with minimal training and perform multiple tests on whole blood using either venous or finger stick samples. The system provides test results in less than 14 minutes with the precision and accuracy equivalent to a clinical laboratory. Contact: Clint Severson Chief Executive Officer ABAXIS, Inc. 510-675-6500 The RCG Group Joe Dorame, Joe Diaz & Robert Blum 480-675-0400 DATASOURCE: ABAXIS, Inc. CONTACT: Clint Severson, Chief Executive Officer of ABAXIS, Inc., +1-510-675-6500; or Joe Dorame, Joe Diaz, or Robert Blum, all of The RCG Group, +1-480-675-0400, for ABAXIS, Inc. Web site: http://www.abaxis.com/

Copyright